surmount-1 tirzepatide non-diabetic obesity trial SURMOUNT‐1 study design. This is a phase 3, multicenter, randomized, Gastrointestinal tolerability and weight reduction
Pay in 4 interest-free payments of $7.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
























